united kingdomen
Image

RobecoSAM Global Gender Equality Impact Equities IE EUR

ISIN: LU2145459850
  • Investing in gender equality creates positive impact—Delivers positive long-term shareholder returns by selecting companies with a strong competitive advantage from recognizing and acting on the strategic importance of improving gender equality.
  • Contribution to the UN Sustainable Development Goals —Supports the achievement of the Sustainable Development Goals by investing in companies that exhibit strength in the retention of female talent, equal remuneration and employee well-being.
Asset class
Current price ()
Performance YTD ()
Currency EUR
Total size of fund ()
Dividend payingYes

About this fund

The RobecoSAM Global Gender Equality Impact Equities Strategy invests globally in companies that are leaders in promoting gender diversity and equality. Through this strategy, we aim to drive change at companies, ultimately creating a positive societal impact.

Price development

No performance data available

Price development

RobecoSAM Global Gender Equality Impact Equities IE EUR

Performance

{{'fund.detail.general.perDate' | labelize:[ fundDate(fund.fundPerformances.date,'llll') ]}}
Fund Reference index
1 month
3 months
YTD
1 year
2 years
3 years
5 years
10 years
{{'fund.detail.performance.period.sinceInception' | labelize:[ fundDate(fund.fundPerformances.sinceStart.startDate,'MM-YYYY') ]}}
The value of the investments may fluctuate. Past performance is no guarantee of future results.
Annualized (for periods longer than one year)
Initial charges or eventual custody charges which intermediaries might apply are not included.
Performances are gross of fees and based on closing values. In reality, costs (such as management fees and other costs) are charged. These have a negative effect on the returns shown.

Performances are net of fees and based on transaction prices.
Fund Reference index
The value of the investments may fluctuate. Past performance is no guarantee of future results.
Annualized (for periods longer than one year)
Initial charges or eventual custody charges which intermediaries might apply are not included.
Performances are gross of fees and based on closing values. In reality, costs (such as management fees and other costs) are charged. These have a negative effect on the returns shown.

Performances are net of fees and based on transaction prices.

Performance explanation

{{'fund.detail.general.perDate' | labelize:[ fundDate(fund.fundInvestmentExplanations.date,'llll') ]}}

Based on transaction prices, the fund's return was 7.00%. During the month, the fund underperformed the benchmark. Lowes underperformed the sector despite delivering strong sales growth, as its reported margin was less than expected. Management guided on a flat margin for the next quarter, due to investments in improving productivity. We view the company’s incremental investments as strategically sound to better position the business for the long term. Not owning Tesla in the fund detracted from performance. Shares of Tesla performed strongly and it will be included in the S&P 500 Index. Thermo Fisher, a strong contributor year-to-date gave back some gains last month, as the market viewed Covid-19 tailwinds waning once vaccines are adopted. However, we view the company as a solid compounder, with a broad portfolio of assets, and a beneficiary of the increasing demand for drugs, vaccines research and production over the long term. S&P Global underperformed the sector. It announced a merger with IHS Markit, an all-stock transaction. The strategic rationale behind the merger is sound, will enhance its position and the ability to drive synergies. Quality names such as First Republic, Nestlé, Novozymes and American Water lagged in performance relative to their sectors.

Statistics

{{'fund.detail.general.perDate' | labelize:[ fundDate( (fund.fundStatistics.date?fund.fundStatistics.date:fund.fundCharacteristics.date) ,'llll') ]}}
3 years 5 years
Tracking error ex-post (%)
Information ratio
Sharpe ratio
Alpha (%)
Beta
Standard deviation
Max. monthly gain (%)
Max. monthly loss (%)
Above mentioned ratios are based on gross of fees returns.
3 years 5 years
Months outperformance
Hit ratio (%)
Months Bull market
Months outperformance Bull
Hit ratio Bull (%)
Months Bear market
Months outperformance Bear
Hit ratio Bear (%)
Above mentioned ratios are based on gross of fees returns.
Fund Reference index
Rating
Option Adjusted Modified Duration (years)
Maturity (years)
Yield to Worst (%)
Green Bonds (%)

Dividend paying history

Date Amount

Market development

{{'fund.detail.general.perDate' | labelize:[ fundDate(fund.fundInvestmentExplanations.date,'llll') ]}}

Global equities rallied strongly on better-than-expected vaccine efficacy rates and the outcome of the US elections. This materially reduced the two tail risks for markets, despite still high Covid-19 infection rates around the world. Pfizer/BioNTech and Moderna’s early Phase 3 trial results showed impressive efficacy, bringing hopes for a sustained economic upswing. After a less-bad-than-feared earnings season, earnings revisions are now turning more positive. China’s manufacturing PMI continued to recover, with new orders improving, while in the US, it stabilized with a slight decline in new orders. Given the high valuation spread between value and growth, there was a sharp reversal of established trends on the back of improved sentiment and positive vaccine announcements. Sectors that lagged the most year-to-date, outperformed the most. Value style outperformed strongly; energy performed best, followed by financials that benefited from improved sentiment and potential earnings uplift from lower provisions. According to the World Economic Forum, it will take 257 years to close the economic gender gap. This is sobering news and presents an opportunity to accelerate change.

Fund allocation

{{'fund.detail.general.perDate' | labelize:[ fundDate(fund.fundAllocations.date,'llll') ]}}
Name Sector Weight
{{fund.fundInvestmentExplanations.top10}}

Fund Classification

YesNoN/A 
Voting
Engagement
ESG integration
Exclusion
YesNoN/A 
Screening
Integration
Sustainability Themed Fund

Currency policy

The fund is allowed to pursue an active currency policy to generate extra returns and can engage in currency hedging transactions.

Dividend policy

In principle, this share class of the fund does distribute dividend.

ESG Integration policy

RobecoSAM Gender Equality Impact Equities invest in companies that are leading with regard to the promotion of gender equality. It employs systematic, bottom-up stock selection that combines proprietary Environmental, Social & Governance (ESG) data and research throughout the investment process. ESG criteria for exclusions and fund-specific suitability are applied during universe construction. An in-house Sustainability Investing (SI) research team integrates financially-material sector and company-specific sustainability analysis into investment cases. A dedicated thematic equity team incorporate SI research within fundamental analysis and stock valuations. Impact assessments of controversial incidences affecting portfolio holdings provide additional risk management. An active ownership and engagement team interacts directly with company management of fund holdings, offering additional channels for sustainable impact.

Investment policy

Our investment philosophy is grounded in the core belief that the integration of ESG factors into a disciplined, research-driven investment process leads to better-informed investment decisions and better risk-adjusted returns through an economic cycle. Building on our proprietary data and research, we identify companies that generate a competitive advantage through sound business practices, efficiency improvements, and the creation of new solutions for the myriad challenges facing society over the coming decades. Taking a long-term investment perspective, we analyze companies’ business models, market positioning and growth potential, and evaluate their financial performance and valuation. Based on this fundamental assessment, we seek to uncover attractive investment opportunities and implement them in concentrated, conviction-based equity portfolios.

Risk policy

Risk management is fully integrated into the investment process to ensure that positions always meet predefined guidelines.

Expectation of fund manager

{{'fund.detail.general.perDate' | labelize:[ fundDate(fund.fundFacts.date,'llll') ]}}

The prospect of highly effective Covid-19 vaccines being approved is propelling the markets. We expect the positive momentum to continue. However, the road to normalization is likely to be bumpy. The Covid outbreak should be brought fully under control at some point next year with effective vaccines, while the pandemic may get worse before it gets better over the coming months. The economic consequences of the virus spread are still severe, with a more sustained economic upswing likely a few quarters out. In the US, the initial jobless claims are still at an elevated level, standing at 778k, while at the peak of the global financial crisis, this number reached 665k per week. Monetary and fiscal stimulus should continue to support equities, and we remain focused on sustainable high-quality companies that exhibit a high degree of gender equality and make use of current market conditions to further solidify positions in companies with appealing mid-term to long-term perspectives.

Junwei Hafner-Cai, CIIA
Junwei Hafner-Cai, CIIA

Junwei Hafner-Cai, CIIA

Junwei Hafner-Cai is the Portfolio Manager for the Global Gender Equality Impact Equities strategy and deputy Portfolio Manager for the Global SDG Equities strategy. Prior, Junwei was also a Senior Analyst covering thematic research within Robeco’s Thematic Equities Team. Prior to joining Robeco, Junwei was a Junior Portfolio Manager at EFG International. Previously, she was an Assistant Relationship Manager within the International Wealth Management Desk at Credit Suisse. She began her investment career as an Assistant Fixed Income Portfolio Manager at Wegelin & Co., Private Bankers. Junwei holds a Bachelor’s degree in Business, major in Banking & Finance from Nanyang Technological University (Singapore) and is a Certified International Investment Analyst (CIIA). She joined Robeco in 2010.

Details

{{'fund.detail.general.perDate' | labelize:[ fundDate(fund.fundFacts.date,'llll') ]}}
Management company
Fund capital
Size of share class
Outstanding shares
ISINLU2145459850
BloombergRSGGIIE LX
Valoren55666665
WKNA2QD2J
Availability
1st quotation date1603929600000
Close financial year31-12
Legal status
Tracking error limit (%)
Reference index

Cost of this fund

Ongoing charges

This fund deducts ongoing charges of
These charges comprise
Management fee
Service fee

Transaction costs

The expected transaction costs are

Performance fee

This fund may also deduct a performance fee of

Extra fees

max entry fee
Max exit fee
Max sub fee
Max switch fee

Fiscal product treatment

The fund is established in Luxembourg and is subject to the Luxembourg tax laws and regulations. The fund is not liable to pay any corporation, income, dividend or capital gains tax in Luxembourg. The fund is subject to an annual subscription tax ('tax d'abonnement') in Luxembourg, which amounts to 0.01% of the net asset value of the fund. This tax is included in the net asset value of the fund. The fund can in principle use the Luxembourg treaty network to partially recover any withholding tax on its income.

Fiscal treatment of investor

Investors who are not subject to (exempt from) Dutch corporate-income tax (e.g. pension funds) are not taxed on the achieved result. Investors who are subject to Dutch corporate-income tax can be taxed for the result achieved on their investment in the fund. Dutch bodies that are subject to corporate-income tax are obligated to declare interest and dividend income, as well as capital gains in their tax return. Investors residing outside the Netherlands are subject to their respective national tax regime applying to foreign investment funds. We advise individual investors to consult their financial or tax adviser about the tax consequences of an investment in this fund in their specific circumstances before deciding to invest in the fund.

Logo

Disclaimer

Please read this important information before proceeding further. It contains legal and regulatory notices relevant to the information contained on this website.

The information contained in the Website is NOT FOR RETAIL CLIENTS - The information contained in the Website is solely intended for professional investors, defined as investors which (1) qualify as professional clients within the meaning of the Markets in Financial Instruments Directive (MiFID), (2) have requested to be treated as professional clients within the meaning of the MiFID or (3) are authorized to receive such information under any other applicable laws. The value of the investments may fluctuate. Past performance is no guarantee of future results. Investors may not get back the amount originally invested. Neither Robeco Institutional Asset Management B.V. nor any of its affiliates guarantees the performance or the future returns of any investments. If the currency in which the past performance is displayed differs from the currency of the country in which you reside, then you should be aware that due to exchange rate fluctuations the performance shown may increase or decrease if converted into your local currency.

In the UK, Robeco Institutional Asset Management B.V. (“ROBECO”) only markets its funds to institutional clients and professional investors. Private investors seeking information about ROBECO should visit our corporate website www.robeco.com or contact their financial adviser. ROBECO will not be liable for any damages or losses suffered by private investors accessing these areas.

In the UK, ROBECO Funds has marketing approval for the funds listed on this website, all of which are UCITS funds. ROBECO is authorized by the AFM and subject to limited regulation by the Financial Conduct Authority. Details about the extent of our regulation by the Financial Conduct Authority are available from us on request.

Many of the protections provided by the United Kingdom regulatory framework may not apply to investments in ROBECO Funds, including access to the Financial Services Compensation Scheme and the Financial Ombudsman Service. No representation, warranty or undertaking is given as to the accuracy or completeness of the information on this website.

If you are not an institutional client or professional investor you should therefore not proceed. By proceeding please note that we will be treating you as a professional client for regulatory purposes and you agree to be bound by our terms and conditions.

If you do not accept these terms and conditions, as well as the terms of use of the website, please do not continue to use or access any pages on this website.

I Disagree